Patents Assigned to NUTRIBAND, INC.
  • Patent number: 12318492
    Abstract: An abuse deterrent and misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
    Type: Grant
    Filed: September 18, 2023
    Date of Patent: June 3, 2025
    Assignee: NUTRIBAND, INC.
    Inventors: David James Enscore, Frank Tagliaferri, Steven Paul Damon, Alan Smith, Jeffrey C. Gaulding
  • Patent number: 11759431
    Abstract: An abuse deterrent and misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
    Type: Grant
    Filed: January 5, 2022
    Date of Patent: September 19, 2023
    Assignee: NUTRIBAND, INC.
    Inventors: David James Enscore, Frank Tagliaferri, Steven Paul Damon, Alan Smith, Jeffrey C. Gaulding
  • Patent number: 11246840
    Abstract: An abuse deterrent and misuse deterrent transdermal patch comprising aversive agents incorporated in the backing layer of the patch. The aversive agents can exhibit biphasic or sustained kinetics of release with an immediate portion released rapidly and an extended portion released in a prolonged manner when exposed to a dissolution medium. The prolonged aversive agent release provides deterrence against extraction of drug from fresh and used patches and serves to prevent accidental misuse of used patches by children. The abuse deterrent and misuse deterrent patch systems can be used for transdermal delivery of therapeutically active agents and particularly those drugs that are highly prone to abuse such as opiate and opioid analgesics and stimulants.
    Type: Grant
    Filed: December 9, 2019
    Date of Patent: February 15, 2022
    Assignee: NUTRIBAND, INC.
    Inventors: David James Enscore, Frank Tagliaferri, Steven Paul Damon, Alan Smith, Jeffrey C. Gaulding